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Abstract 
Autophagy is a catabolic membrane trafficking process involved in degradation of 
cellular constituents through lysosomes, which maintains cell and tissue homeostasis.  
While much attention has been focused on autophagic turnover of cytoplasmic materials, 
little is known regarding the role of autophagy in degrading nuclear components.  Here 
we report that the autophagy machinery mediates degradation of nuclear lamina 
components in mammalian cells, a process we term laminophagy.  The autophagy protein 
LC3 is present in the nucleus and directly interacts with the nuclear lamina protein Lamin 
B1, and associates with lamin-associated domains (LADs) on chromatin.  This interaction 
does not downregulate Lamin B1 during starvation, but mediates its degradation upon 
tumorigenic insults, such as by oncogenic Ras. Laminophagy is achieved by nucleus-to-
cytosol transport that delivers Lamin B1 to the lysosome for degradation.  Inhibiting 
autophagy or LC3-Lamin B1 interaction prevents oncogenic Ras-induced Lamin B1 loss 
and delays oncogene-induced cell cycle arrest.  Our study unveils a role for autophagy in 
degrading nuclear materials, and suggests laminophagy as a guarding mechanism 
protecting cells from tumorigenesis. 
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Text 
Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved 
trafficking event that forms double-membrane autophagosomes enclosing cellular 
contents which fuse with late endosomes or lysosomes for degradation of enclosed 
materials1-3.  Autophagy maintains cell and tissue integrity, and is essential during 
starvation1-4.  Dysfunction of autophagy is involved in a number of diseases1-3,5-9.  
Because autophagosomes are observed in the cytosol, extensive studies have focused on 
autophagic degradation of cytosolic materials.  However, several autophagy proteins have 
been detected in the nucleus, one of which is the well-known microtubule-associated 
protein light chain 3 (LC3)10-13. LC3 undergoes a ubiquitin-like conjugation modification 
that couples the lipid phosphatidylethanolamine to LC3 (termed LC3-II) to facilitate its 
binding to membranes14-17. LC3 is involved in autophagosome maturation and delivery of 
selective autophagy substrates to autophagosomes16,18,19.  Intriguingly, an abundant pool 
of LC3 resides in the nucleus in the basal state, and, upon autophagy induction, LC3 
diminishes its nuclear abundance and forms cytosolic puncta10,12,13.  The nuclear mobility 
of LC3 is slow13, indicating it may interact with a high molecular-weight complex13.  
However, the nature of this putative interaction is not known.  
We initiated this study by investigating LC3 distribution in IMR90 primary human lung 
fibroblasts, cultured in physiological oxygen (3%). Young proliferating IMR90 cells 
(population doubling 24) were subjected to subcellular fractionation (Fig. 1a). This 
revealed a substantial amount of endogenous LC3 in the nuclear fraction, and a small but 
reproducible amount of lipidated LC3-II in the nucleus (Fig. 1a). Consistent with the 
presence of nuclear LC3-II, Atg7 and Atg5-Atg12, proteins that mediate LC3 lipidation, 
are also present in the nucleus in small amounts (Fig. 1a), congruent with recent reports 
of nuclear functions of Atg5 and Atg720,21.  
To understand the nuclear binding partners of LC3, we used bacterially purified GST-
LC3B (hereafter referred to as LC3, unless specified otherwise) to pull down the isolated 
nuclear fraction (Fig. 1b). One protein that we found to interact with LC3 is the nuclear 
lamina protein Lamin B1 (Fig. 1b). The nuclear lamina is a fibrillar network beneath the 
nuclear envelope, composed of nuclear lamins and associated proteins22-24. In addition to 
providing the nucleus with mechanical strength, nuclear lamina also regulates higher 
orders of chromatin organization modulating gene expression and silencing22-24.  In 
contrast to Lamin B1 binding, Lamins A/C bind poorly to LC3 (Fig. 1b). Using purified 
Lamin B1 protein (Suppl Fig. 1a), we detected a direct interaction between LC3B and 
Lamin B1 (Fig. 1c), and found that LC3A and LC3C bind to purified Lamin B1 likewise 
(Suppl Fig. 1b). Co-immunoprecipitation (co-IP) of endogenous LC3 in HEK293T (Fig. 
1d) and IMR90 (Fig. 1e) pulled down endogenous Lamin B1, but little Lamins A/C (Fig. 
1d and 1e). In addition, IP of LC3 in IMR90 cytosol and nucleus fractions reveals that the 
interaction occurs in the nucleus (Fig. 1f). Notably, the Lamin B1-co-precipitated LC3 is 
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predominately the LC3-II form (Fig. 1e), suggesting LC3 lipidation is involved. 
Consistent with this, the lipidation deficient LC3-G120A mutant15 showed impaired 
binding to Lamin B1 (Fig. 1g); this was specific, as the p62 binding deficient LC3-F52A 
mutant25 does not affect the interaction with Lamin B1 (Fig. 1g). Also in contrast to LC3, 
Beclin 1 and ULK1 showed little or no interaction with Lamin B1 (Fig. 1g). Likewise, 
Lamin B1 showed decreased binding to LC3 in Atg5-deficient MEFs (Suppl Fig. 1c). 
Taken together, these data suggest that LC3 directly interacts with Lamin B1, and that 
LC3 lipidation facilitates this interaction, possibly by tethering LC3 to the nuclear lamina 
where the interaction occurs. A schematic model is illustrated in Fig. 5f (a).  
Lamin B1 is known to associate with transcriptionally inactive heterochromatin domains, 
termed lamin-associated domains (LADs)22,23,26. We used chromatin immunoprecipitation 
(ChIP) to investigate the association of LC3 with LADs, in proliferating IMR90 cells.  
ChIP of Lamin B1 coupled with quantitative PCR (qPCR) validated that Lamin B1 
associates with LADs but poorly with euchromatin regions, such as β-actin and PCNA 
promoters (Suppl Fig. 2a). To investigate the interaction of LC3 with chromatin, we first 
ectopically expressed GFP or GFP-LC3, and performed GFP ChIP. Similarly to Lamin 
B1 ChIP, GFP-LC3 precipitates LADs but not β-actin or PCNA promoters (Suppl Fig. 
2b). This association with LADs is dependent on LC3 lipidation, since the LC3-G120A 
mutant shows deficient binding to LADs (Fig. 2a, left), although expressed at comparable 
level to LC3 WT (Fig. 2a, right).  We next tested whether endogenous LC3 associates 
with chromatin.  ChIP of endogenous LC3 reveals similar binding to LADs but not the 
two euchromatic gene promoter regions (Fig. 2b). Knockdown of LC3 by shRNA 
reduced the signal of LC3 association with LADs (Suppl Fig. 2c), showing the specificity 
of the LC3 antibody.  
We then performed endogenous LC3 ChIP followed by genome-wide parallel sequencing 
(ChIP-seq) in proliferating IMR90 cells.  We mapped LC3 ChIP-seq data to the reference 
human genome (NCBI v36), quantified binding enrichment by normalization to the 
number of billions of bases sequenced and to input DNA, and assessed the enrichment 
map compared to that of our previously published Lamin B1 ChIP-seq27 (Fig. 2c, 
example is shown for whole chromosome 10 in upper tracks, and zoom-in view in lower 
tracks).  At the genome-wide scale, LC3 is highly enriched at LADs relative to an equal 
number of size-matched randomly selected non-LAD control regions (Fig. 2d, Mann-
Whitney p-value <2.2×10-16).  To further define LC3-associated chromatin, we measured 
LADs and non-LAD control regions for ChIP-seq enrichment by specific histone 
markers, including Lys4 trimethylation on histone H3 (H3K4me3) that is canonically 
associated with active promoters of transcribed genes, and H3K9me3 that represents 
constitutive heterochromatin regions highly enriched in LADs28 (Fig. 2e).  This analysis 
revealed that the level of LC3 enrichment strongly correlates with that of Lamin B1 and 
H3K9me3, but not with H3K4me3, specifically over LADs but not in non-LAD control 
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regions (Fig. 2e).  These data indicate that, at the genome-wide level, LC3 associates with 
constitutive heterochromatic regions over LADs. Hence, LC3 not only interacts with 
Lamin B1, but also associates with LADs on chromatin, as illustrated in Fig. 5f (a). 
We then probed for possible biological functions of this interaction. Starvation or 
rapamycin treatment of IMR90 cells caused decreased protein level of autophagy 
substrate p62 (Fig. 3a), however, Lamin B1 protein level remain unchanged (Fig. 3a). 
These data indicate that autophagy does not degrade Lamin B1 during starvation. One 
disruptive scenario that involves Lamin B1 loss is oncogenic insult, such as oncogenic 
Ras29-32.  Indeed, most primary cells and tissues cope with oncogenic Ras activity by 
inducing cellular senescence, a stable cell cycle arrest that serves as a tumor suppressive 
mechanism33-35.  We and others have shown that Lamin B1, but not Lamins A/C, is 
dramatically downregulated during oncogene-induced senescence (OIS), both in vitro and 
in vivo29-32. Importantly, autophagy is upregulated during OIS36, and autophagic activity 
has been shown to be required for the mitosis-to-senescence transition36,37. Given these 
connections between autophagy and oncogene activities, we hypothesized that activated 
oncogenes trigger autophagic degradation of Lamin B1 in primary human cells.   
When proliferating IMR90 cells were exposed to oncogenic HRasV12, the cells induce 
p16INK4a (hereafter referred to as p16), a senescence biomarker, accompanied by 
downregulation of Lamin B1, but not Lamins A/C (Fig. 3b), consistent with previous 
findings31.  Stable expression of GFP-Lamin B1 leads to an expression pattern at the 
nuclear periphery in proliferating cells (Fig. 3c). Starvation does not alter the Lamin B1 
pattern (Fig. 3c). In contrast, HRasV12 expression induces nuclear membrane blebbing, 
and, occasionally, cytosolic GFP signals (Fig. 3c).  Transmission electron microscopy 
(TEM) analysis of HRasV12-expressing cells confirmed the induction of 
autophagosomes, reduction of perinuclear heterochromatin, and induction of nuclear 
membrane blebbing (Suppl Fig. 3a).  This nuclear membrane blebbing is morphologically 
distinct from yeast piecemeal microautophagy38, in which nuclear blebs are in direct 
contact with cytosolic vacuoles that result in the pinching-off of nuclear blebs to the 
vacuoles through nucleus-vacuole junctions38.  Here we found no evidence of cytosolic 
vacuoles in direct contact with nuclear blebs (Suppl Fig. 3a).  
The weak cytosolic GFP-Lamin B1 signal in HRasV12 cells (Fig. 3c) indicates that it 
may undergo degradation.  In fact, GFP is sensitive to acidic quenching, and by contrast, 
mCherry is more stable in the acidic environment. Thus a tandem mCherry-GFP fused 
with an autophagy substrate is useful to track acidic lysosomal degradation39.  Here, a 
yellow signal (due to merged mCherry and GFP) indicates the fusion protein is in a 
normal pH environment, whereas a red signal (due to quenching of GFP) indicates the 
protein has undergone lysosomal degradation. This technique is frequently used for LC3 
and p62 for monitoring autophagy flux10,12,39. mCherry-GFP-Lamin B1 showed yellow 
nuclear peripheral pattern in control cells (Fig. 3d), but displayed cytosolic red signal in 
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HRasV12-expressing cells (Fig. 3d). Quantitative analysis of the two channels revealed 
that, while both GFP and mCherry are enriched at the nuclear periphery, mCherry-only 
fluorescence is detected in the cytosol of HRasV12 cells (Fig. 3d, right panel and graph). 
These data indicate that Lamin B1 undergoes cytosolic lysosomal degradation.  Further, 
the mCherry-GFP-Lamin B1 technique allowed us to readily quantify that cytosolic 
Lamin B1 and nuclear membrane blebbing are specifically induced by HRasV12, but not 
by starvation or rapamycin treatment (Fig. 3e, left and middle groups).   
We next performed live-cell imaging with mCherry-GFP-Lamin B1 expressing HRasV12 
IMR90 cells (Fig. 3f). This revealed a nucleus-to-cytosol transport process, through 
nuclear membrane blebbing (as highlighted by arrows in events 1 to 3; see close-up 
images in lower panels left to right), which then leads to Lamin B1 degradation in the 
cytosol (note the initial yellow signal, followed by disappearance of GFP then mCherry, 
in events 1 and 3; event 2 was not yet degraded by the end of the imaging) (Fig. 3f).  
Because the nuclear export and degradation of Lamin B1 is a dynamic and transient 
process (Fig. 3f), the results in Fig. 3e are likely underestimated.    
The cytosolic Lamin B1 in HRasV12 cells is reminiscent of the cytoplasmic chromatin 
fragments (CCFs) that we previously described in senescent cells, which are Lamins 
A/C-negative, but are DAPI-, γ-H2AX- and H3K27me3-positive fragments of 
heterochromatin budded off from the nuclei, through nuclear membrane blebbing, and are 
targeted by the lysosomal machinery31.  Consistent with the behavior of Lamin B1 (Fig. 
3e, left and middle groups), we found cytosolic DAPI (that represents the CCFs) 
specifically appearing in response to HRasV12, but not starvation or rapamycin treatment 
(Fig. 3e, right group). The cytosolic DAPI staining bodies also stain positive for 
H3K27me3 (Suppl Fig. 3b and 3c), consistent with our previous observations31.  
Importantly, CCFs colocalize with overexpressed or endogenous LC3 (Suppl Fig. 3b and 
3c, and Suppl Fig. 4a and 4b). Moreover, endogenous or overexpressed cytosolic Lamin 
B1 colocalizes with LC3 (Fig. 3g and Suppl Fig. 3c).  In addition, we performed pre-
embedded immuno-gold TEM of endogenous Lamin B1.  While a gentle detergent in the 
permeabilization step is beneficial in preserving the ultrastructures, we found that a 
strong detergent (e.g., Triton X-100) was necessary to deliver the antibody to the nuclear 
lamina.  Although the ultrastructure is compromised, we were able to observe apparent 
Lamin B1 gold particles beneath the nuclear envelope in control cells (Fig. 3h).  In sharp 
contrast, HRasV12-expressing cells show loss of nuclear lamina signal, and the 
appearance of cytosolic gold particles, usually in aggregates, inside the autophagic 
vacuoles (Fig. 3h, and quantified in lower panels). Taken together, these data indicate 
that Lamin B1 is an autophagy substrate upon oncogene insults, which, through a 
nucleus-to-cytosol transport process, leads to autophagic degradation in the cytosol, as 
illustrated in Fig. 5f (b-c). 
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We subsequently investigated the functional consequence of inhibition of autophagy.  
Estrogen receptor-tagged HRasV12 was induced by adding 4-hydroxytamoxifen (4-OHT) 
in IMR90 cells expressing a non-targeting control or an sh-Atg7 hairpin (Fig. 4a). While 
control cells show progressive downregulation of Lamin B1, Atg7 knockdown cells show 
reduced LC3 lipidation, and significantly impaired Lamin B1 downregulation (Fig. 4a 
and quantitation shown in 4b).  Lamin B1 mRNA has been shown to decrease upon 
HRasV12 expression29,30. We found that the mRNA level of Lamin B1 is reduced in both 
control and Atg7 knockdown cells (Suppl Fig. 5a), whereas the protein level of Lamin B1 
is maintained in Atg7 deficient cells (Fig. 4a and 4b). These data show that, in response 
to oncogenic Ras, Lamin B1 is downregulated at both mRNA and protein levels, and that 
autophagic degradation of the protein is crucial for Lamin B1 loss. 
Reduced Lamin B1 is associated with compromised nuclear lamina integrity and barrier 
function31,40, resulting in the nuclei being more permeable to fluorescent high molecular 
weight dextrans31.  While control HRasV12-expressing cells show nuclear permeation of 
both 70 and 500-kD dextrans, Atg7 knockdown cells show reduced dextran-positive 
nuclei (Fig. 4c), indicating increased integrity of the nuclear lamina.  In another 
approach, where we transiently treated primary BJ fibroblasts with the DNA damaging 
agent etoposide and cultured the cells in regular medium for more than 2 weeks, the cells 
showed decreased Lamin B1 (Suppl Fig. 5b). In contrast, knockdown of Atg7 (with a 
different shRNA from used in Fig. 4a) impaired Lamin B1 downregulation (Suppl Fig. 
5b).  The observation that Lamins A/C remain unchanged (Fig. 3b and Suppl Fig. 5b) is 
consistent with their inability to interact with LC3 (Fig. 1).   
Lamin B1 plays an important role in cell proliferation and senescence29.  Forced 
knockdown of Lamin B1 causes impaired proliferation or premature senescence27,29,40,41.  
In line with the compromised degradation of Lamin B1, Atg7 knockdown cells showed 
delayed HRasV12-induced senescence, as judged by reduced levels of p16 using 
immunoblotting (Suppl Fig. 5c) and reduced activity of senescence-associated beta-
galactosidase (β-gal) (Suppl Fig. 5d), consistent with previous findings that disruption of 
autophagy delays the onset of oncogene-induced senescence36,37.  
To further dissect the underlying molecular mechanisms, we mapped the LC3-Lamin B1 
interaction.  Among the critical residues and domains of LC3, LC3 R10 and R11 were 
found to be essential for binding to Lamin B1, from in vitro pull-down and co-IP 
experiments (Fig. 4d and Suppl Fig. 6a and 6b). This interaction is unusual compared to 
other LC3 binding partners18,19, as the first 28 amino acids of LC3 is sufficient for the 
interaction, and the LC3 C-terminal ubiquitin-like domain (30-128) is not required for 
interaction (Fig. 4d).   
Due to the redundant roles of LC3 family proteins in binding to Lamin B1 (e.g., Suppl. 
Fig. 1b), it is difficult to manipulate the interaction in vivo from the LC3 end. We thus 
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performed an unbiased mapping of Lamin B1 in its interaction with LC3 (Fig. 4e).  Using 
overexpressed or in vitro translated truncations and internal deletions, we found that the 
linker region between Coil 2 and the Ig-fold of Lamin B1 is necessary for LC3 binding 
(Fig. 4e, and Suppl Fig. 6c and 6d).  Truncation of this region, but not others, resulted in 
abrogated binding to LC3 in vitro (Fig. 4e, and Suppl Fig. 6c and 6d).  Strikingly, this 
linker region (390-438) is the most evolutionarily conserved domain among all vertebrate 
Lamin B1 proteins (Fig. 4f), indicating a potentially important function. This region 
(390-438, 49 amino acids) along with 20 amino-acid flanking sequences at the N- and C-
terminus (resulting in an 89 amino-acid fragment 370-458) is sufficient to bind LC3 (Fig. 
4e bottom, and Suppl Fig. 7a and 7b), while the 49 amino-acid region itself (390-438) 
failed to bind LC3 (Fig. 4e and Suppl Fig. 7b), likely due to a defect in proper peptide 
folding.  The 370-458 region of Lamin B1 contains its nuclear localization signal (NLS) 
(Fig. 4e), and thus the 89 amino-acid fragment localizes to the nucleus (Fig. 4g), and is 
able to interact with endogenous LC3 (Fig. 4h).  We further found that overexpression of 
this fragment decreases endogenous LC3-Lamin B1 interaction (Fig. 4h), likely due to a 
competition with Lamin B1 to bind LC3; in contrast, overexpression of the fragment does 
not affect LC3 lipidation (Fig. 4h), LC3 binding to p62 (Fig. 4h), or p62 degradation 
upon starvation (Suppl Fig. 7c), indicating an intact autophagy pathway. When expressed 
in the HRasV12 IMR90 cells, the fragment impaired Lamin B1 downregulation, 
accompanied by a delayed p16 induction (Fig. 4i), which is a phenocopy of the Atg7 
knockdown cells (Fig. 4a and Suppl Fig. 5c).  Collectively, these data suggest that 
inhibiting autophagy or LC3-Lamin B1 interaction causes impaired autophagic 
degradation of Lamin B1.     
We then proceeded to identify the residues in Lamin B1 required for binding to LC3. We 
first performed 10 amino-acid truncations within the Lamin B1 390-438 region, using in 
vitro translated proteins, and found that the first 30 amino acids are required for 
association with LC3 (Suppl. Fig. 8a).  This 30 amino-acid region is evolutionarily highly 
conserved (Suppl. Fig. 8b).  Unbiased substitution mutagenesis within this region 
revealed that residues S393, S395, S396, R397, and V398 are essential for LC3 binding 
(Fig. 5a and Suppl. Fig. 8c), and simultaneously substituting these residues to alanine 
abrogated the interaction in vitro (Fig. 5a, hereafter referred to as Lamin B1 Mut), while 
substituting other residues had little or no effect (Suppl. Fig. 8c). The residues of the NLS 
of Lamin B1 415-419 are not required for the interaction in vitro (Suppl. Fig. 8c).  When 
expressed in cells, the substitution mutant showed a normal nuclear peripheral pattern 
(Suppl. Fig. 9a), and is able to interact with endogenous Lamin A and Lamin B1 (Suppl. 
Fig. 9b), indicating the mutant behaves normally at the nuclear lamina.  Co-IP of the 
Lamin B1 substitution mutant shows deficient binding of endogenous LC3 (Fig. 5b). The 
remaining slight interaction of the mutant with LC3 (Fig. 5b) is most likely via 
endogenous Lamin B1 present in cells, as the Lamin B1 substitution mutant shows 
normal association with endogenous Lamin B1 (Suppl. Fig. 9b) that binds to LC3.  
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Importantly, when expressed in HRasV12 IMR90 cells, the Lamin B1 mutant showed 
deficient downregulation compared to WT Lamin B1 (Fig. 5c, compare WT in middle 
lanes to Mut in right lanes).  Further, while mCherry-GFP-Lamin B1 WT HRasV12 cells 
show cytosolic DAPI (CCF) and cytosolic mCherry signal (Fig. 5d upper panel and Fig. 
3d-g), strikingly, the mutant shows dramatically reduced cytosolic DAPI and mCherry 
signals (Fig. 5d lower panels). In contrast, the mutant displayed massive nuclear 
membrane blebbings that are unable to export to the cytosol (Fig. 5d). Quantification of 
more than 200 cells revealed that the mutant has significantly decreased CCF and 
cytosolic mCherry-Lamin B1, while showing intact ability to induce nuclear membrane 
blebbing (Fig. 5e).  These results indicate that the mutant has a profound deficiency in 
nucleus-to-cytosol transport.  Consequently, the mutant-expressing cells delayed 
HRasV12-induced senescence with a higher efficiency than WT Lamin B1, as measured 
by β-gal activity (Suppl. Fig. 9c).  In summary, these data strongly suggest that Lamin B1 
binding to LC3 is not involved in the step of nuclear membrane blebbing, but is essential 
for the subsequent nuclear export to cytosol.  Blocking the nucleus-to-cytosol transport 
inhibits laminophagy and delays senescence imposed by oncogenic Ras.    
In this study, we presented the first nuclear interaction partner of the autophagy protein 
LC3, showing that LC3 interacts with Lamin B1 and associated LADs on chromatin (Fig. 
5f, a).  This interaction specifically mediates laminophagy upon tumorigenic and 
genotoxic insults, such as by oncogenic Ras and DNA damage (Fig. 5f, b and c).  
Notably, laminophagy does not occur upon starvation.  Recent studies on Lamin B1, 
including ours, revealed that downregulation of Lamin B1 damages the integrity of the 
nuclear lamina, reduces cell proliferation or causes premature senescence, and leads to 
large scale alterations in the epigenome that is associated with global gene expression 
changes27,29,31,40,41.  These dramatic changes are beneficial in restraining tumorigenesis, 
but are unlikely to be the strategies to cope with starvation, a physiological condition that 
repetitively occurs for all living organisms.   
While the detailed molecular mechanisms triggering laminophagy are out of the scope of 
the current study, our work highlights that autophagy proteins reside at the nuclear lamina 
in the basal state and trigger laminophagy upon aberrant insults.  Inhibiting laminophagy 
prevents the downregulation of Lamin B1 and delays oncogene-induced cell cycle arrest, 
as shown, first, by Atg7 knockdown, second, by overexpression of Lamin B1 peptide that 
competes endogenous LC3-Lamin B1 binding, and, third, by expression of a Lamin B1 
substitution mutant that fails to associate with LC3.  Thus, laminophagy serves as a 
potential guarding mechanism, protecting cells and tissues from oncogenic 
transformation.  In addition to oncogene activation, laminophagy may function in other 
scenarios.  Recent studies show that autophagy contributes to degradation of mutant 
lamin proteins in laminopathies42,43, a group of genetic diseases caused by mutations of 
nuclear lamin proteins24,44,45.  Additionally, stress associated with cancer cells produces 
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micronuclei and/or cytosolic chromatin, which can mediate cancer cell death46,47.  
Finally, we have previously detected cytosolic chromatins in aged tissue31.  Taken 
together, these studies suggest that laminophagy responds to abnormal cellular insults, 
and may play a role in maintaining cell and tissue integrity.  Dysregulated laminophagy 
may therefore contribute to tumorigenesis and age-related diseases.  
While our current work focused on LC3 and Lamin B1, we anticipate that other 
autophagy proteins/interactions have roles in the nucleus in orchestrating laminophagy 
and other physiological conditions.  This study establishes a new angle in understanding 
autophagy from the perspective of the nucleus.    
 
Methods 
Complete methods are described in supplemental information. 
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Figure Legends 
Figure 1. LC3 interacts with nuclear lamina protein Lamin B1. 
a, Proliferating young IMR90 (PD24) cultured in 3% oxygen was subjected to subcellular 
fractionation and probed for indicated antibodies.  b, The nucleus fraction of IMR90 as in 
a was pulled down with bacterially expressed and purified GST or GST-LC3B, and 
probed with Lamin antibodies. Quantification of relative binding to LC3 is shown on 
right. Data shown are the average values of three independent experiments. Error bars: 
s.e.m. * p<0.0001. c, GST-LC3B pulldown of purified Lamin B1 protein, showing a 
direct interaction. d and e, Endogenous co-IP in HEK293T (d) and IMR90 (e). f, The 
cytosol and nucleus fractions of IMR90 were subjected to LC3 IP. The IP and input are 
shown.  g, HEK293T cells were transfected with GFP-tagged constructs, and subjected to 
GFP IP and western blot analysis. Relative binding of Lamin B1 is quantified and shown 
on right. Data are the mean values of three independent experiments. Error bars: s.e.m. * 
p<0.001. 
 
Figure 2. LC3 associates with LADs on chromatin.  
a, IMR90 (PD24) stably expressing GFP-tagged constructs were subjected to ChIP with 
GFP antibody, and qPCR for LADs primers or promoter regions of β-actin and PCNA. 
Results shown are the average values of three independent experiments. Error bars: s.e.m.  
* p<0.05, ** p<0.01, mutant compared with WT, n.s., non-significant.  Immunoblots of 
the input and GFP IP are shown on right. b, LC3 ChIP of young proliferating IMR90 
cells, and qPCR quantitation of LADs and two promoter regions. Results shown are the 
mean values of three independent experiments. Error bars: s.e.m. * p<0.01, ** p<0.005, 
n.s., non-significant. c-e, ChIP-seq analysis of LC3 in proliferating IMR90 cells (PD24), 
revealing colocalization of LC3 and Lamin B1. c, Upper: Representative tracks of LC3 
and previously published Lamin B1 and LADs over chromosome 10. LC3 is shown in 
blue, and Lamin B1 and LADs are shown in yellow. Lower: Representative zoom-in 
view over a 500 kb region on chromosome 10 (chr10: 99,449,723-99,949,723), showing 
a LAD. Note the apparent overlap of LC3 over LADs. The relative position of this region 
is indicated with a black line under the upper track. d, Box plot representation of Lamin 
B1 and LC3 ChIP-seq enrichment aligned to LADs and randomly selected non-LAD 
control regions, showing a preferential enrichment of LC3 in LADs (data presented are 
the ratio of ChIP-seq tags to input, log2 scale; Mann-Whitney test, *** p<2.2×10-16). e, 
Correlation heat plot of LC3 and Lamin B1 with H3K4me3 and H3K9me3 ChIP-seq, 
over randomly selected non-LAD control regions or LADs, revealing that LC3, Lamin 
B1, and H3K9me3 correlate strongly in LADs but not in control regions.  Data shown are 
normalized against corresponding background for each ChIP.  
 
Figure 3. Lamin B1 is an autophagy substrate in response to oncogene insult. 
a, IMR90 cells were left untreated or treated with amino-acid starvation, amino-acid plus 
serum starvation, or rapamycin (500 nM) for 1 and 2 days. Cell lysates were subjected to 
immunoblotting. b, IMR90 cells were infected with control virus or retrovirus expressing 
HRasV12 for 7 days, and subjected to immunoblotting analysis. c, IMR90 stably 
expressing GFP-Lamin B1 were left untreated or starved in Hanks buffer for 1 day or 
infected with HRasV12 for 7 days. Representative confocal fluorescent microscopy 
images are shown. Note the nuclear membrane blebbing and cytosolic GFP, as indicated 
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by arrows. d, IMR90 stably expressing mCherry-GFP-Lamin B1 were infected with 
control virus or HRasV12 virus for 7 days. Representative confocal microscopy images 
are shown. Quantification of fluorescent intensities of mCherry and GFP channels are 
shown on right. e, mCherry-GFP-Lamin B1 IMR90 were treated with indicated, and 
quantification of each condition is shown. Data presented are the mean values of 4 
different fields with over 200 cells. Error bars: s.d.  * p<0.01, ** p<0.001.  f, mCherry-
GFP-Lamin B1 HRasV12 IMR90 were imaged for a duration of overnight under 
spinning-disc confocal microscopy. Images were taken every 15 mins, and representative 
pictures are shown from one cell.  Image shown are the maximum-projection combining 
all Z-sections.  Nucleus-to-cytosol transport events are labelled sequentially as indicated. 
Selected events are highlighted in insets. Note the nuclear export of events 1-3, and 
disappearance of events 1 and 3.  Event 2 was not yet degraded by the end of the 
imaging. g, mCherry-GFP-Lamin B1 IMR90 cells were stained with LC3 antibody, and 
imaged under confocal microscopy. Representative images are shown.  CCFs are denoted 
by arrows. h, Control and HRasV12 IMR90 cells were subjected to pre-embedded 
staining with Lamin B1 antibody and were gold-enhanced. Sections were processed for 
TEM analysis.  Representative nuclear lamina in control cells and autophagic vacuoles 
are shown in insets.  Quantification with over 20 randomly selected and imaged cells are 
shown at the bottom. Error bars: s.e.m.  
 
Figure 4. Inhibiting autophagy or LC3-Lamin B1 interaction impairs Lamin B1 
degradation. 
a, ER:HRasV12 IMR90 cells were stably infected with lentivirus encoding non-targeting 
control hairpin (sh-NTC) or sh-Atg7 hairpin. HRasV12 was induced by addition of 4-
OHT for indicated days. Cell lysates were analyzed by western blotting with antibodies 
indicated. b, Quantification of Lamin B1 from western blotting of three independent 
experiments. Error bars: s.e.m.  * p<0.05, ** p<0.005, *** p<0.0001, compared with sh-
NTC Day 0. n.s., non-significant. c, Nuclei from indicated cells were incubated with 70 
kDa or 500 kDa Dextrans, and Dextran positive nuclei were scored. Results shown are 
the average values of three independent scorings. Error bars: s.d. * p<0.005.  d, Purified 
Lamin B1 protein was subjected to GST pull-down of GST-LC3B WT or mutants. Note 
that the R10A/R11A mutant shows impaired binding to Lamin B1.  e, Schematic 
illustration of Lamin B1 mutants in binding to LC3. f, Conservation analysis of Lamin B1 
domains in vertebrates.  Within each domain, the number of conserved residues is 
calculated and normalized to the total number of residues.  All residues in Lamin B1 are 
quantified and presented as total. g, mCherry-GFP-Lamin B1 370-458 was stably 
expressed in IMR90 and imaged under confocal microscopy.  h, HEK293T transfected 
with mCherry-GFP tagged proteins were subjected to LC3 IP, and analyzed as indicated. 
i, ER:HRasV12 IMR90 cells stably expressing indicated constructs were harvested every 
two days, and subjected to western blotting analysis.    
 
Figure 5. Lamin B1 mutant that does not bind to LC3 shows deficiency in nucleus-
to-cytosol transport. 
a, In vitro translated Lamin B1 mutants were subjected to GST-LC3 pulldown. The 
pulldown and input are shown. Results shown are representative of three independent 
experiments. b, HEK293T cells were transfected with Lamin B1 WT or mutant construct, 
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and subjected to LC3 IP and immunoblotting analysis. c, ER:HRasV12 IMR90 cells 
expressing WT or mutant Lamin B1 were induced with 4-OHT and harvested at indicated 
days. Cell lysates were analyzed with indicated antibodies. d, mCherry-GFP-Lamin B1 
WT or Mut expressing HRasV12 IMR90 cells were analyzed under confocal microscopy. 
Cells were harvested at Day 6 post Ras induction. Note that while WT Lamin B1 cells 
show cytosolic DAPI and mCherry, the Mut cells show massive nuclear membrane 
blebbings, but are deficient in nuclear export to cytosol. e, Cells as in d were quantified 
for cytosolic DAPI (CCF), cytosolic mCherry signal (cytosolic Lamin B1), and nuclear 
membrane blebbing. Results presented are the mean values from no less than 4 different 
fields with over 200 cells. Error bars: s.d. * p<0.05, ** p<0.005, *** p<0.0001.  f, 
Schematic illustration of laminophagy. (a), In the basal state, nuclear LC3 resides at 
nuclear lamina through its lipidation. The un-lipidated LC3 is localized in nuclear plasma 
that does not associate with nuclear lamina. Note that LC3 also associates with LADs on 
chromatin.  (b and c), Upon nuclear lamina damage (e.g. by oncogene), nuclear 
membrane blebbing is formed that transports pieces of nuclear lamina to cytosol, forming 
the cytoplasmic chromatin fragments (CCFs) that are initially positive for DAPI, Lamin 
B1, and LC3. The CCFs are then targeted by cytosolic autophagy machinery, leading to 
autophagic degradation.  
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